CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE14750.05-114.25 (-0.77 %)
PREV CLOSE () 14864.30
OPEN PRICE () 14801.05
BID PRICE (QTY) 14735.05 (1)
OFFER PRICE (QTY) 14768.60 (1)
VOLUME 1060
TODAY'S LOW / HIGH ()14678.00 15443.00
52 WK LOW / HIGH ()4928 16544.75
NSE14700.00-189.05 (-1.27 %)
PREV CLOSE() 14889.05
OPEN PRICE () 14880.00
BID PRICE (QTY) 14690.20 (2)
OFFER PRICE (QTY) 14700.00 (23)
VOLUME 31207
TODAY'S LOW / HIGH() 14650.05 15480.00
52 WK LOW / HIGH ()4926.05 16560.75
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office :

Address : 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone : 040-67611600 / 67611700

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
20Nov Neuland Laboratories informs about inv
Neuland Laboratories has informed that it enclosed the schedule of group..
07Nov Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
06Nov Neuland Laboratories informs about pre
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
16Oct Clarification On Recent News In The M
Clarification on recent news in the media / social media
15Oct Neuland Laboratories informs about ce
Neuland Laboratories has informed that it attached the certificate as re..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit319.592995.96
Gross Profit 485.39 4007.69
Operating Profit 656.754744.65
Net Sales 3108.4415585.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Strides Pharma Scien (BSE)
 1499.25 (7.67%)
M.Cap ( in Cr)
13748.67
Divi's Lab (BSE)
 5989.80 (1.59%)
M.Cap ( in Cr)
157972.39
Concord Biotech (BSE)
 1989.60 (4.80%)
M.Cap ( in Cr)
20693.61
Alkem Laboratories (BSE)
 5610.25 (1.54%)
M.Cap ( in Cr)
66871.51
AMI Organics (BSE)
 2096.25 (3.56%)
M.Cap ( in Cr)
8540.77
Shareholding Pattern
NON-INSTITUTION 34.11%
PROMOTERS 32.64%
MUTUAL FUNDS/UTI 4.04%
FI/BANKS/INSURANCE 0.4%
GOVERNMENT 0.4%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77172.41-405.97 (-0.52%)
NIFTY23335.45-183.05 (-0.78%)
Dow Jones 43408.47139.53 (0.32%)
Nasdaq 18966.14-21.33 (-0.11%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI